Identification of Novel Glycolysis-Related Gene Signatures Associated With Prognosis of Patients With Clear Cell Renal Cell Carcinoma Based on TCGA

Akram, 2013, Mini-review on glycolysis and cancer., J. Cancer Educ., 28, 454, 10.1007/s13187-013-0486-9

Colman, 2019, The clinical and mutational spectrum of B3GAT3 linkeropathy: two case reports and literature review., Orphanet J. Rare. Dis., 14, 10.1186/s13023-019-1110-9

Courtney, 2018, Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo., Cell Metab., 28, 793, 10.1016/j.cmet.2018.07.020

Dang, 2011, Therapeutic targeting targrting of cnacer cell metabolism., J. Mol. MED., 89, 205, 10.1007/s00109-011-0730-x

Dang, 2009, MYC-induced cancer cell energy metabolism and therapeutic opportunities., Clin. Cancer Res., 15, 6479, 10.1158/1078-0432.CCR-09-0889

DeBerardinis, 2008, The biology of cancer: metablic reprogramming fuels cell growth and proliferation., Cell Metab., 7, 11, 10.1016/j.cmet.2007.10.002

Fan, 2015, Prognostic significance of hypoxia-inducible factor expression in renal cell carcinoma: a prisma-compliant systematic review and meta-analysis., Medicine, 94, 10.1097/MD.0000000000001646

Ferlay, 2010, Estimates of worldwide burden of cancer in2008: GLOBOCAN 2008., Int. J. Cancer, 127, 2893, 10.1002/ijc.25516

Fourment, 2008, A comparison of common programming languages used in bioinformatics., BMC Bioinform., 9, 10.1186/1471-2105-9-82

Fu, 2015, Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway., J. Hematol. Oncol., 8, 10.1186/s13045-015-0117-5

Ganapathy-Kanniappan, 2013, Tumor glycolysis as a target for cancer therapy: progress and prospects., Mol. Cancer, 12, 10.1186/1476-4598-12-152

Gatenby, 2004, Why do cancers have high aerobic glycolysis?, Nat. Rev. Cancer, 4, 891, 10.1038/nrc1478

Gill, 2016, Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response., Biochim. Biophys. Acta, 1866, 87, 10.1016/j.bbcan.2016.06.005

Guerra, 2017, Mitochondria and cancer chemoresistance., Biochim. Biophys. Acta Bioenerget., 1858, 686, 10.1016/j.bbabio.2017.01.012

Guin, 2014, Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease., J. Natl. Cancer Inst., 106, 10.1093/jnci/dju062

Harami-Papp, 2016, Ambrus A, Hauser P, Szabó A, Tretter L, Gyõrffy B. TP53 mutation hits energy metabolism and increases glycolysis in breast cancer., Oncotarget, 7, 67183, 10.18632/oncotarget.11594

Heiden, 2009, Understanding the warburg effect: the metabolic requirements of cell proliferation., Science, 324, 1029, 10.1126/science.1160809

Howman, 2000, Early disruption of centromeric chromatin organization in centromere protein A (Cenpa) null mice., Proc. Natl. Acad. Sci. U.S.A., 97, 1148, 10.1073/pnas.97.3.1148

Jonasch, 2014, Renal cell carcinoma., BMJ, 349, 10.1136/bmj.g4797

Li, 2007, Expression of centromere protein A in hepatocellular carcinoma., Zhonghua Bing Li Xue Za Zhi, 36, 175

Liberzon, 2015, The Molecular Signatures Database (MSigDB) hallmark gene set collection., Cell Syst., 1, 417, 10.1016/j.cels.2015.12.004

Liberzon, 2011, Molecular signatures database (MSigDB) 3.0., Bioinformatics, 27, 1739, 10.1093/bioinformatics/btr260

Linehan, 2019, The metabolic basis of kidney cancer., Cancer Discov., 9, 1006, 10.1158/2159-8290.CD-18-1354

Lunt, 2011, Aerobic glycolysis: meeting the metabolic requirements of cell proliferation., Annu. Rev. Cell Dev. Biol., 27, 441, 10.1146/annurev-cellbio-092910-154237

Makhov, 2018, Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies., Mol. Cancer Ther., 17, 1355, 10.1158/1535-7163.MCT-17-1299

Miller, 2019, Cancer treatment and survivorship statistics., CA Cancer J. Clin., 69, 363, 10.3322/caac.21565

Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes., Nat. Genet., 34, 267, 10.1038/ng1180

Murray, 2003, Harper’s Illustrated Biochemistry.

Nilsson, 2015, Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate., Cell Death Dis., 6, 10.1038/cddis.2014.545

Oldenburg, 2016, CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)., BMC Cancer, 16, 10.1186/s12885-016-2756-5

Otto, 2016, Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism., Cancer Metab., 4, 10.1186/s40170-016-0145-9

Qiu, 2019, Research on circadian clock genes in common abdominal malignant tumors., Chronobiol. Int., 36, 906, 10.1080/07420528.2018.1477792

Rajput, 2011, Immunohistochemical assessment of expression of centromere protein-A (CENPA) in human invasive breast cancer., Cancers, 3, 4212, 10.3390/cancers3044212

Revu, 2018, IL-23 and IL-1β Drive Human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation., Cell Rep., 22, 2642, 10.1016/j.celrep.2018.02.044

Ruan, 2019, High expression of TAZ serves as a novel prognostic biomarker and drivers cancer progression in renal cancer., Exp. Cell Res., 376, 181, 10.1016/j.yexcr.2019.02.001

Shuch, 2013, Aerobic glycolysis: a novel target in kidney cancer., Expert Rev. Anticancer Ther., 13, 711, 10.1586/era.13.57

Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles., Proc. Natl. Acad. Sci. U.S.A., 102, 15545, 10.1073/pnas.0506580102

Sun, 2016, Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers., Int. J. Cancer, 139, 899, 10.1002/ijc.30133

Tomonaga, 2003, Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer., Cancer Res., 63, 3511

Tone, 1999, Characterization of recombinant human glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans., FEBS Lett., 459, 415, 10.1016/s0014-5793(99)01287-9

Valdivia, 2009, CENPA a genomic marker for centromere activity and human diseases., Curr. Genomics, 10, 326, 10.2174/138920209788920985

Villar, 2015, Glutaminolysis and autophagy in cancer., Autophagy, 11, 1198, 10.1080/15548627.2015.1053680

Wang, 2016, A Practical Guide to the cancer Genome Atlas (TCGA)., Methods Mol. Biol., 1418, 111, 10.1007/978-1-4939-3578-9_6

Warburg, 1956, On the origin of cancer cells., Science, 123, 309, 10.1126/science.123.3191.309

Wu, 2012, Expression and prognostic significance of centromere protein A in human lung adenocarcinoma., Lung Cancer, 77, 407, 10.1016/j.lungcan.2012.04.007

Xiao, 2018, GLUT1 regulates cell glycolysis and proliferation in prostate cancer., Prostate, 78, 86, 10.1002/pros.23448

Zhang, 2019, An immune-related signature predicts survival in patients with lung adenocarcinoma., Front. Oncol., 9, 10.3389/fonc.2019.01314

Zhu, 2020, Energy metabolism in cancer stem cells., World J. Stem Cell, 12, 448, 10.4252/wjsc.v12.i6.448